| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/25/1997 | EP0779818A1 Liquid immunoglobulin formulations |
| 06/25/1997 | EP0779817A1 Enteral vaccine for vaginal infections |
| 06/25/1997 | EP0556248B1 Mycobacterium as adjuvant for antigens |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152935A Papillomavirus vaccines |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
| 06/25/1997 | CN1152878A Improved modified live BRSV vaccine |
| 06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/24/1997 | US5641870 Low pH hydrophobic interaction chromatography for antibody purification |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641865 Surfactant stabilized microheterogeneous dispersion of aqueous phase containing antibody or fragment thereof in water immiscible medium |
| 06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
| 06/24/1997 | US5641761 Feeding crustacea food containing water-soluble schizophyllan and mycelia of schizophyllan-producing fungus |
| 06/24/1997 | US5641760 Method of treating candida infection |
| 06/24/1997 | US5641680 For gene therapy treatment |
| 06/24/1997 | US5641677 Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8+ T cells |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
| 06/24/1997 | US5641637 Method of preparing lyophilized and frozen cell standards |
| 06/24/1997 | US5641492 Broad spectrum vaccine for immunizing animals against gramnegative bacteria comprising killed suspension of bacterial mutant, detoxified lipopolysaccharide immune modulator, protein and lipid binding carrier |
| 06/24/1997 | US5641491 Escherichia coli strain 364 and use of said strain as a vaccine |
| 06/24/1997 | US5641490 Recombinant avipox virus comprising exogenous dna from infectious bursal disease virus inserted into nonessential region of avipox virus genome, which expresses structural protein coded for by said exogenous dna |
| 06/24/1997 | US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/24/1997 | US5641474 Prevention of autoimmune diseases by aerosol administration of autoantigens |
| 06/24/1997 | US5641473 Treatment of autoimmune diseases by aerosol administration of autoantigens |
| 06/24/1997 | US5641471 Method for preparing 213 Bi for therapeutic use |
| 06/20/1997 | CA2193315A1 Human mucin (muc8) |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021727A1 Mycoplasma recombinant polypeptide vaccines |
| 06/19/1997 | WO1997021450A1 Ox-2 costimulatory molecule |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | WO1997016221A3 Genetic induction of receptors for targeted radiotherapy |
| 06/19/1997 | WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0779297A1 Antigenic peptides with glycine substitutions |
| 06/18/1997 | EP0778948A1 Predictive test for hepatitis-b resistance |
| 06/18/1997 | EP0778894A1 Infectious peritonitis vaccine |
| 06/18/1997 | EP0778892A1 Macrophage derived chemokine and chemokine analogs |
| 06/18/1997 | EP0778888A1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/18/1997 | EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/18/1997 | EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 06/18/1997 | EP0778781A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 06/18/1997 | EP0778780A1 Capsular polysaccharide immunomodulator |
| 06/18/1997 | EP0580635B1 Modified plant viruses as vectors |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | EP0512017B1 Vaccines |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | EP0447483B1 Dopamine receptors and genes |
| 06/18/1997 | CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2 |
| 06/17/1997 | US5639947 Genetic engineering |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639857 Ultrapurification of factor IX and other vitamin k-dependent proteins |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639855 Adrenomedullin |
| 06/17/1997 | US5639854 Amino acid sequence of a t-cell epitope of the gag protein of hiv-1; vaccines |
| 06/17/1997 | US5639853 Respiratory syncytial virus vaccines |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639650 cDNA clone for South African Arbovirus No. 86 |
| 06/17/1997 | US5639649 Polio virus mutants; vaccines |
| 06/17/1997 | US5639641 Resurfacing of rodent antibodies |
| 06/17/1997 | US5639637 Pure protein free of blood products comprising a sequence of variant hepatitis b s protein, said protein comprising a modified a determinant of an s protein in which amino acid at position 145 is arginine |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639601 Synthetic peptide sequences useful in detection of foot and mouth disease |
| 06/17/1997 | US5639594 Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| 06/17/1997 | US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy |
| 06/17/1997 | US5639462 Attenuated polyiviruses vaccine containing them and vaccination methods using them |
| 06/17/1997 | US5639461 Heat inactivated whole influenza virus with thimerosal; free of formalin and beta-propiolactone |
| 06/17/1997 | US5639457 Introducing dna sequence coding for rearranged antibody into male pronucleus of fertilized ovum; implanting in pig or rabbit; transgenic offspring produce antibodies |
| 06/17/1997 | US5639440 Administering mixture of polypeptide and immunogen to transgenic mammal having tolerance for polypeptide yields antibody capable of binding immunogen |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997021104A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | WO1997021103A1 Treatment and diagnosis of infections due to helicobacter pylori |
| 06/12/1997 | WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | WO1997020934A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 06/12/1997 | WO1997020854A1 Recombinant gas vesicles and uses thereof |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020577A1 Improved therapeutic formulation and method |
| 06/12/1997 | WO1997020576A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020468A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 06/12/1997 | WO1997014964A3 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 06/12/1997 | WO1997012972A3 Regulated genes and uses thereof |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | DE19545472A1 Diagnosis of squamous epithelial cell carcinoma |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |